Isabelle Grau

Experience

• 

  Servier Laboratories

  Jan 2002 - Jan 2004

  Working primarily in field of Mild Cognitive Impairment, I was responsible for program set up and management of Phase I clinical trial in Berlin, Germany and international Phase II study in Neuroimagery, as well as program development of novel molecule including Phase III trials.

  • Chef D'Etudes Clinique

    Jan 2002 - Jan 2004

  • Clinical Research Associate

    Jan 2002 - Jan 2004
• 

  I3 Research

  Jan 2004 - Jan 2012

  Responsible for the successful management of global, large and small clinical trial projects throughout Asia Pacific, including Australia, New Zealand, South Korea, Taiwan, Philippines, Malaysia, Hong Kong, Singapore and India. Lead CRA role on numerous global studies, phase I to IV, across Asia Pacific.

  • Project Manager

    Jan 2008 - Jan 2012

  • Senior Clinical Research Associate

    Jan 2004 - Jan 2008
• 

  InVentiv Health Clinical

  Feb 2013 - Oct 2015

  Regional Operational Director for Late Stage programs (Observational/NIS and interventional studies) in Asia Pacific, including China and India.Strategic and regulatory program planning and costing, including proposal development and writing. Business growth and development for China, South Korea, Taiwan, India, Hong Kong, Australia & New Zealand, the Philippines, Singapore, Malaysia and Vietnam. Regional Lead in Late Stage Operations Australasia Pacific region, including China and India.

  • Director, Late Stage Operations Asia Pacific

    May 2014 - Oct 2015

  • Associate Director, Late Stage Operations APAC

    Feb 2013 - Apr 2014
• 

  Mapi Group

  Feb 2016 - Feb 2018

  Director of Operations, Real World Evidence APAC

  As regional Director of Operations- APAC, I am responsible for leading and overseeing the successful operational execution of all Real World Evidence studies across APAC, as well as building new business opportunities for the future growth of Mapi in the Austral-Asian market.

• 

  ICON plc

  Feb 2018 - now

  Head Of Clinical Operations Commercialisation and Outcomes Research Asia Pacific